"","SMAD4","APC","RBP1","RPS6KA1","INTS4","KRAS","CAPN1","MYLK","CACNA1B","SP5"
"Glucuronidation",0.648256931938629,0,0,0.569576609517278,0,0,0,0,0,0
"Collagen chain trimerization",0.898111409404793,0.841825808959102,0.839855231513335,0,0.843404020699388,0.839211408830943,0.840118338488555,0.838867965546911,0,0
"FGFR4 ligand binding and activation",0.812735780502225,0.814127907046885,0.744535300538401,0.817745275004098,0.741221079584055,0.885547600140141,0.81859993384839,0.817130607948217,0.746896081294245,0.754095058315957
"Phospholipase C-mediated cascade; FGFR4",0.812735780502225,0.814127907046885,0.7444831682633,0.817745275004098,0.741221079584055,0.885547600140141,0.818369499448576,0.817130607948217,0.746896081294245,0.754044416721993
"Formation of axial mesoderm",0.630006276945657,0.481052127631201,0.339693525041686,0,0.331105079323193,0.323195930131231,-0.00906136252319738,0,0,0.165782887966233
"Phase II - Conjugation of compounds",0.630544388051455,0.523324336237613,0.576318909576285,0.575601833110773,0.526869404125669,0,0,0,0,0
"FGFR2c ligand binding and activation",0.760470205758725,0.754644864496667,0.656973910647733,0.767495605162108,0.762107612052283,0.854805044143447,0.768694193109963,0.759990427186699,0.764698915276777,0.670382766409963
"Peptide hormone biosynthesis",0.814007362198879,0,0.3955982602934,0.552767225229126,0,0,0,0,0.543230401738624,0
"Primitive streak formation",0.58429383765844,0.153467810231439,0,0,0,-0.023285652404331,-0.0118017928360442,0,0,0.185629072268733
